Enrolment has been completed in a phase III study evaluating salmon calcitonin for vertebral fractures in postmenopausal women.

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1651, 2008-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alexza Pharmaceuticals has announced that it has completed enrolment in its second phase III trial with loxapine

By  

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Enrolment into phase III study of telaprevir begins.

By  

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis

By Rosner A.J.  

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 559-573

Adis International

Access to resources Recommend Favorite

Enrolment has commenced for a new phase I trial evaluating the combination of AE 37 and another HER-2/neu-based cancer vaccine

By  

Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline (GSK) has discontinued enrolment into its phase III trial of the HIV entry inhibitor, aplaviroc [GW 873140]

By  

Reactions Weekly, Vol. 1, Iss. 1076, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite